The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies editorial

Over the last decade, transplantation of circulating autologous hematopoietic stem cells to facilitate the recovery of bone marrow (BM) function following administration of marrow ablative anti-cancer therapy has been used with increasing frequency. During that time, a number of indications for peripheral stem cell transplantation (PSCT) emerged